New York, Sept. 19, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Brain Tumor Diagnosis and Treatment Industry" - https://www.reportlinker.com/p05960584/?utm_source=GNW 5 Million by 2027, growing at aCAGR of 7.4% over the period 2020-2027. Primary Brain Tumor, one of the segments analyzed in the report, is projected to record 7.2% CAGR and reach US$587.1 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Secondary Brain Tumor segment is readjusted to a revised 7.9% CAGR for the next 7-year period. The U.S. Market is Estimated at $145.3 Million, While China is Forecast to Grow at 11.2% CAGR The Brain Tumor Diagnosis and Treatment market in the U.S. is estimated at US$145.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$197 Million by the year 2027 trailing a CAGR of 11.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4% and 6.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.We bring years of research experience to this 7th edition of our report. The 381-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed. Competitors identified in this market include, among others,
- AstraZeneca PLC
- Carestream Health, Inc.
- GE Healthcare
- Hitachi Medical Corporation
- Merck & Co., Inc.
- Pfizer, Inc.
- Philips Healthcare
- Shimadzu Corporation
- Siemens Healthineers
- Toshiba Medical Systems Corporation
Read the full report: https://www.reportlinker.com/p05960584/?utm_source=GNW I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Global Competitor Market Shares Brain Tumor Diagnosis and Treatment Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE Table 1: World Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 Table 2: World Historic Review for Brain Tumor Diagnosis and Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 3: World 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027 Table 4: World Current & Future Analysis for Primary Brain Tumor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 Table 5: World Historic Review for Primary Brain Tumor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 6: World 15-Year Perspective for Primary Brain Tumor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 7: World Current & Future Analysis for Secondary Brain Tumor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 Table 8: World Historic Review for Secondary Brain Tumor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 9: World 15-Year Perspective for Secondary Brain Tumor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 10: World Current & Future Analysis for CT Scan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 Table 11: World Historic Review for CT Scan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 12: World 15-Year Perspective for CT Scan by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 13: World Current & Future Analysis for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 Table 14: World Historic Review for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 15: World 15-Year Perspective for MRI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 16: World Current & Future Analysis for PET-CT Scan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 Table 17: World Historic Review for PET-CT Scan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 18: World 15-Year Perspective for PET-CT Scan by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 19: World Current & Future Analysis for Other Diagnosis Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 Table 20: World Historic Review for Other Diagnosis Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 21: World 15-Year Perspective for Other Diagnosis Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 22: World Current & Future Analysis for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 Table 23: World Historic Review for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 24: World 15-Year Perspective for Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 25: World Current & Future Analysis for Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 Table 26: World Historic Review for Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 27: World 15-Year Perspective for Radiation Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 28: World Current & Future Analysis for Targeted Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 Table 29: World Historic Review for Targeted Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 30: World 15-Year Perspective for Targeted Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 31: World Current & Future Analysis for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 Table 32: World Historic Review for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 33: World 15-Year Perspective for Chemotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 34: World Current & Future Analysis for Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 Table 35: World Historic Review for Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 36: World 15-Year Perspective for Immunotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 III. MARKET ANALYSIS GEOGRAPHIC MARKET ANALYSIS UNITED STATES Market Facts & Figures US Brain Tumor Diagnosis and Treatment Market Share (in %) by Company: 2019 & 2025 Market Analytics Table 37: USA Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 38: USA Historic Review for Brain Tumor Diagnosis and Treatment by Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 39: USA 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2012, 2020 & 2027 Table 40: USA Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 41: USA Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 42: USA 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan and Other Diagnosis Types for the Years 2012, 2020 & 2027 Table 43: USA Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 44: USA Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 45: USA 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy for the Years 2012, 2020 & 2027 CANADA Table 46: Canada Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 47: Canada Historic Review for Brain Tumor Diagnosis and Treatment by Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 48: Canada 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2012, 2020 & 2027 Table 49: Canada Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 50: Canada Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 51: Canada 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan and Other Diagnosis Types for the Years 2012, 2020 & 2027 Table 52: Canada Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 53: Canada Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 54: Canada 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy for the Years 2012, 2020 & 2027 JAPAN Table 55: Japan Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 56: Japan Historic Review for Brain Tumor Diagnosis and Treatment by Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 57: Japan 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2012, 2020 & 2027 Table 58: Japan Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 59: Japan Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 60: Japan 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan and Other Diagnosis Types for the Years 2012, 2020 & 2027 Table 61: Japan Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 62: Japan Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 63: Japan 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy for the Years 2012, 2020 & 2027 CHINA Table 64: China Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 65: China Historic Review for Brain Tumor Diagnosis and Treatment by Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 66: China 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2012, 2020 & 2027 Table 67: China Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 68: China Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 69: China 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan and Other Diagnosis Types for the Years 2012, 2020 & 2027 Table 70: China Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 71: China Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 72: China 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy for the Years 2012, 2020 & 2027 EUROPE Market Facts & Figures European Brain Tumor Diagnosis and Treatment Market: Competitor Market Share Scenario (in %) for 2019 & 2025 Market Analytics Table 73: Europe Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 Table 74: Europe Historic Review for Brain Tumor Diagnosis and Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 75: Europe 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 Table 76: Europe Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 77: Europe Historic Review for Brain Tumor Diagnosis and Treatment by Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 78: Europe 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2012, 2020 & 2027 Table 79: Europe Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 80: Europe Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 81: Europe 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan and Other Diagnosis Types for the Years 2012, 2020 & 2027 Table 82: Europe Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 83: Europe Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 84: Europe 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy for the Years 2012, 2020 & 2027 FRANCE Table 85: France Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 86: France Historic Review for Brain Tumor Diagnosis and Treatment by Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 87: France 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2012, 2020 & 2027 Table 88: France Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 89: France Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 90: France 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan and Other Diagnosis Types for the Years 2012, 2020 & 2027 Table 91: France Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 92: France Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 93: France 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy for the Years 2012, 2020 & 2027 GERMANY Table 94: Germany Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 95: Germany Historic Review for Brain Tumor Diagnosis and Treatment by Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 96: Germany 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2012, 2020 & 2027 Table 97: Germany Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 98: Germany Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 99: Germany 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan and Other Diagnosis Types for the Years 2012, 2020 & 2027 Table 100: Germany Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 101: Germany Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 102: Germany 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy for the Years 2012, 2020 & 2027 ITALY Table 103: Italy Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 104: Italy Historic Review for Brain Tumor Diagnosis and Treatment by Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 105: Italy 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2012, 2020 & 2027 Table 106: Italy Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 107: Italy Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 108: Italy 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan and Other Diagnosis Types for the Years 2012, 2020 & 2027 Table 109: Italy Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 110: Italy Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 111: Italy 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy for the Years 2012, 2020 & 2027 UNITED KINGDOM Table 112: UK Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 113: UK Historic Review for Brain Tumor Diagnosis and Treatment by Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 114: UK 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2012, 2020 & 2027 Table 115: UK Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 116: UK Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 117: UK 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan and Other Diagnosis Types for the Years 2012, 2020 & 2027 Table 118: UK Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 119: UK Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 120: UK 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy for the Years 2012, 2020 & 2027 SPAIN Table 121: Spain Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 122: Spain Historic Review for Brain Tumor Diagnosis and Treatment by Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 123: Spain 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2012, 2020 & 2027 Table 124: Spain Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 125: Spain Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 126: Spain 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan and Other Diagnosis Types for the Years 2012, 2020 & 2027 Table 127: Spain Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 128: Spain Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Please contact our Customer Support Center to get the complete Table of Contents Read the full report: https://www.reportlinker.com/p05960584/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________
Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
